The New Drugs and Clinical Trial Rules state the any drug discovered in India and proposed to be manufactured and marketed in India, will be deemed approval for clinical trials in 30 working days, if no communication received from the Central Licensing Authority (CLA).New clinical trial rules to boost growth of clinical research industry
The New Drugs and Clinical Trial Rules state the any drug discovered in India and proposed to be manufactured and marketed in India, will be deemed approval for clinical trials in 30 working days, if no communication received from the Central Licensing Authority (CLA).
Subscribe to:
Post Comments (Atom)
-
Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology f...
-
The bank plans to raise up to Rs 500 crore by issue of equity shares to qualified institutional buyers through qualified institutional plac...
-
In July, HCL Technologies had announced a Rs 4,000 crore buyback programme for FY19 at a price of Rs 1,100 per equity share.
No comments:
Post a Comment